October 2017 - Volume 23 - Issue 10 - Contributor Index

Alphabetical Search

The Current Landscape and Lessons from Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Past, Present, and Future

Allegretti, Jessica; Eysenbach, Lindsay M.; El-Nachef, Najwa; More

Inflammatory Bowel Diseases. 23(10):1710-1717, October 2017.

Guanylate Cyclase C Activation Shapes the Intestinal Microbiota in Patients with Familial Diarrhea and Increased Susceptibility for Crohn's Disease

Tronstad, Rune R.; Kummen, Martin; Holm, Kristian; More

Inflammatory Bowel Diseases. 23(10):1752-1761, October 2017.

Genetic and Transcriptomic Bases of Intestinal Epithelial Barrier Dysfunction in Inflammatory Bowel Disease

Vancamelbeke, Maaike; Vanuytsel, Tim; Farré, Ricard; More

Inflammatory Bowel Diseases. 23(10):1718-1729, October 2017.

Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort

Bramuzzo, Matteo; Stocco, Gabriele; Montico, Marcella; More

Inflammatory Bowel Diseases. 23(10):1810-1816, October 2017.

Guanylate Cyclase C Activation Shapes the Intestinal Microbiota in Patients with Familial Diarrhea and Increased Susceptibility for Crohn's Disease

Tronstad, Rune R.; Kummen, Martin; Holm, Kristian; More

Inflammatory Bowel Diseases. 23(10):1752-1761, October 2017.

Author:
Barp, Jacopo MD

Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort

Bramuzzo, Matteo; Stocco, Gabriele; Montico, Marcella; More

Inflammatory Bowel Diseases. 23(10):1810-1816, October 2017.

Incidence and Management of Recurrence in Patients with Crohn's Disease Who Have Undergone Intestinal Resection: The Practicrohn Study

Domènech, Eugeni; Garcia, Valle; Iborra, Marisa; More

Inflammatory Bowel Diseases. 23(10):1840-1846, October 2017.

Serum Interleukin 9 Levels Predict Disease Severity and the Clinical Efficacy of Infliximab in Patients with Crohn's Disease

Feng, Ting; Chen, Baili; Li, Li; More

Inflammatory Bowel Diseases. 23(10):1817-1824, October 2017.

Increased Rate of Venous Thromboembolism in Hospitalized Inflammatory Bowel Disease Patients with Clostridium Difficile Infection

Bhandari, Sanjay; Mohammed Abdul, Mubeen Khan; Dhakal, Binod; More

Inflammatory Bowel Diseases. 23(10):1847-1852, October 2017.

IBD LIVE Series—Case 8: Treatment Options for Refractory Esophageal Crohn's Disease and Hidradenitis Suppurativa

Iskandar, Heba; Greer, Julia B.; Krasinskas, Alyssa M.; More

Inflammatory Bowel Diseases. 23(10):1667-1677, October 2017.

  • Video

Premedication Use in Preventing Acute Infliximab Infusion Reactions in Patients with Inflammatory Bowel Disease: A Single Center Cohort Study

Gold, Stephanie L.; Cohen-Mekelburg, Shirley; Schneider, Yecheskel; More

Inflammatory Bowel Diseases. 23(10):1882-1889, October 2017.

Patients with Crohn's Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to Infliximab

Guerbau, Loic; Gerard, Romain; Duveau, Nicolas; More

Inflammatory Bowel Diseases. 23(10):1853-1859, October 2017.

Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort

Bramuzzo, Matteo; Stocco, Gabriele; Montico, Marcella; More

Inflammatory Bowel Diseases. 23(10):1810-1816, October 2017.

Patients with Crohn's Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to Infliximab

Guerbau, Loic; Gerard, Romain; Duveau, Nicolas; More

Inflammatory Bowel Diseases. 23(10):1853-1859, October 2017.

More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing

Broekman, Mark M. T. J.; Coenen, Marieke J. H.; van Marrewijk, Corine J.; More

Inflammatory Bowel Diseases. 23(10):1873-1881, October 2017.

Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort

Bramuzzo, Matteo; Stocco, Gabriele; Montico, Marcella; More

Inflammatory Bowel Diseases. 23(10):1810-1816, October 2017.

Author:
Calvo, Marta MD

Incidence and Management of Recurrence in Patients with Crohn's Disease Who Have Undergone Intestinal Resection: The Practicrohn Study

Domènech, Eugeni; Garcia, Valle; Iborra, Marisa; More

Inflammatory Bowel Diseases. 23(10):1840-1846, October 2017.

Delivering High Value Inflammatory Bowel Disease Care Through Telemedicine Visits

Li, Shawn X.; Thompson, Kimberly D.; Peterson, Tracey; More

Inflammatory Bowel Diseases. 23(10):1678-1681, October 2017.

Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort

Bramuzzo, Matteo; Stocco, Gabriele; Montico, Marcella; More

Inflammatory Bowel Diseases. 23(10):1810-1816, October 2017.

Incidence and Management of Recurrence in Patients with Crohn's Disease Who Have Undergone Intestinal Resection: The Practicrohn Study

Domènech, Eugeni; Garcia, Valle; Iborra, Marisa; More

Inflammatory Bowel Diseases. 23(10):1840-1846, October 2017.

Patients with Crohn's Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to Infliximab

Guerbau, Loic; Gerard, Romain; Duveau, Nicolas; More

Inflammatory Bowel Diseases. 23(10):1853-1859, October 2017.

Incidence and Management of Recurrence in Patients with Crohn's Disease Who Have Undergone Intestinal Resection: The Practicrohn Study

Domènech, Eugeni; Garcia, Valle; Iborra, Marisa; More

Inflammatory Bowel Diseases. 23(10):1840-1846, October 2017.

Comparison of Health Care Utilization and Costs Between Patients with Perianal Fistulizing Crohn's Disease Treated with Biologics with or Without Previous Seton Placement

Schwartz, David A.; Wang, Anthony; Ozbay, Burak; More

Inflammatory Bowel Diseases. 23(10):1860-1866, October 2017.

Author:
Chen, Baili PhD

Serum Interleukin 9 Levels Predict Disease Severity and the Clinical Efficacy of Infliximab in Patients with Crohn's Disease

Feng, Ting; Chen, Baili; Li, Li; More

Inflammatory Bowel Diseases. 23(10):1817-1824, October 2017.

Author:
Chen, Minhu PhD

Serum Interleukin 9 Levels Predict Disease Severity and the Clinical Efficacy of Infliximab in Patients with Crohn's Disease

Feng, Ting; Chen, Baili; Li, Li; More

Inflammatory Bowel Diseases. 23(10):1817-1824, October 2017.

Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort

Bramuzzo, Matteo; Stocco, Gabriele; Montico, Marcella; More

Inflammatory Bowel Diseases. 23(10):1810-1816, October 2017.

SHANK3 Regulates Intestinal Barrier Function Through Modulating ZO-1 Expression Through the PKCε-dependent Pathway

Wei, Shu-Chen; Yang-Yen, Hsin-Fang; Tsao, Po-Nien; More

Inflammatory Bowel Diseases. 23(10):1730-1740, October 2017.

Genetic and Transcriptomic Bases of Intestinal Epithelial Barrier Dysfunction in Inflammatory Bowel Disease

Vancamelbeke, Maaike; Vanuytsel, Tim; Farré, Ricard; More

Inflammatory Bowel Diseases. 23(10):1718-1729, October 2017.

More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing

Broekman, Mark M. T. J.; Coenen, Marieke J. H.; van Marrewijk, Corine J.; More

Inflammatory Bowel Diseases. 23(10):1873-1881, October 2017.

Premedication Use in Preventing Acute Infliximab Infusion Reactions in Patients with Inflammatory Bowel Disease: A Single Center Cohort Study

Gold, Stephanie L.; Cohen-Mekelburg, Shirley; Schneider, Yecheskel; More

Inflammatory Bowel Diseases. 23(10):1882-1889, October 2017.

Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort

Bramuzzo, Matteo; Stocco, Gabriele; Montico, Marcella; More

Inflammatory Bowel Diseases. 23(10):1810-1816, October 2017.

Patients with Crohn's Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to Infliximab

Guerbau, Loic; Gerard, Romain; Duveau, Nicolas; More

Inflammatory Bowel Diseases. 23(10):1853-1859, October 2017.

Delivering High Value Inflammatory Bowel Disease Care Through Telemedicine Visits

Li, Shawn X.; Thompson, Kimberly D.; Peterson, Tracey; More

Inflammatory Bowel Diseases. 23(10):1678-1681, October 2017.

More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing

Broekman, Mark M. T. J.; Coenen, Marieke J. H.; van Marrewijk, Corine J.; More

Inflammatory Bowel Diseases. 23(10):1873-1881, October 2017.

Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort

Bramuzzo, Matteo; Stocco, Gabriele; Montico, Marcella; More

Inflammatory Bowel Diseases. 23(10):1810-1816, October 2017.

More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing

Broekman, Mark M. T. J.; Coenen, Marieke J. H.; van Marrewijk, Corine J.; More

Inflammatory Bowel Diseases. 23(10):1873-1881, October 2017.

Patients with Crohn's Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to Infliximab

Guerbau, Loic; Gerard, Romain; Duveau, Nicolas; More

Inflammatory Bowel Diseases. 23(10):1853-1859, October 2017.

Increased Rate of Venous Thromboembolism in Hospitalized Inflammatory Bowel Disease Patients with Clostridium Difficile Infection

Bhandari, Sanjay; Mohammed Abdul, Mubeen Khan; Dhakal, Binod; More

Inflammatory Bowel Diseases. 23(10):1847-1852, October 2017.

Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort

Bramuzzo, Matteo; Stocco, Gabriele; Montico, Marcella; More

Inflammatory Bowel Diseases. 23(10):1810-1816, October 2017.

Incidence and Management of Recurrence in Patients with Crohn's Disease Who Have Undergone Intestinal Resection: The Practicrohn Study

Domènech, Eugeni; Garcia, Valle; Iborra, Marisa; More

Inflammatory Bowel Diseases. 23(10):1840-1846, October 2017.

Patients with Crohn's Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to Infliximab

Guerbau, Loic; Gerard, Romain; Duveau, Nicolas; More

Inflammatory Bowel Diseases. 23(10):1853-1859, October 2017.

Comparison of Health Care Utilization and Costs Between Patients with Perianal Fistulizing Crohn's Disease Treated with Biologics with or Without Previous Seton Placement

Schwartz, David A.; Wang, Anthony; Ozbay, Burak; More

Inflammatory Bowel Diseases. 23(10):1860-1866, October 2017.

The Current Landscape and Lessons from Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Past, Present, and Future

Allegretti, Jessica; Eysenbach, Lindsay M.; El-Nachef, Najwa; More

Inflammatory Bowel Diseases. 23(10):1710-1717, October 2017.

High Demand for Psychotherapy in Patients with Inflammatory Bowel Disease

Klag, Thomas; Mazurak, Nazar; Fantasia, Laura; More

Inflammatory Bowel Diseases. 23(10):1796-1802, October 2017.

Prevalence and Phenotype of Concurrent Psoriasis and Inflammatory Bowel Disease

Eppinga, Hester; Poortinga, Sietske; Thio, Hok Bing; More

Inflammatory Bowel Diseases. 23(10):1783-1789, October 2017.

The Current Landscape and Lessons from Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Past, Present, and Future

Allegretti, Jessica; Eysenbach, Lindsay M.; El-Nachef, Najwa; More

Inflammatory Bowel Diseases. 23(10):1710-1717, October 2017.

Author:
Faggen, Alec BA

Premedication Use in Preventing Acute Infliximab Infusion Reactions in Patients with Inflammatory Bowel Disease: A Single Center Cohort Study

Gold, Stephanie L.; Cohen-Mekelburg, Shirley; Schneider, Yecheskel; More

Inflammatory Bowel Diseases. 23(10):1882-1889, October 2017.

High Demand for Psychotherapy in Patients with Inflammatory Bowel Disease

Klag, Thomas; Mazurak, Nazar; Fantasia, Laura; More

Inflammatory Bowel Diseases. 23(10):1796-1802, October 2017.

Author:
Fantasia, Laura

High Demand for Psychotherapy in Patients with Inflammatory Bowel Disease

Klag, Thomas; Mazurak, Nazar; Fantasia, Laura; More

Inflammatory Bowel Diseases. 23(10):1796-1802, October 2017.

IBD LIVE Series—Case 8: Treatment Options for Refractory Esophageal Crohn's Disease and Hidradenitis Suppurativa

Iskandar, Heba; Greer, Julia B.; Krasinskas, Alyssa M.; More

Inflammatory Bowel Diseases. 23(10):1667-1677, October 2017.

  • Video

Genetic and Transcriptomic Bases of Intestinal Epithelial Barrier Dysfunction in Inflammatory Bowel Disease

Vancamelbeke, Maaike; Vanuytsel, Tim; Farré, Ricard; More

Inflammatory Bowel Diseases. 23(10):1718-1729, October 2017.

Author:
Feng, Rui PhD

Serum Interleukin 9 Levels Predict Disease Severity and the Clinical Efficacy of Infliximab in Patients with Crohn's Disease

Feng, Ting; Chen, Baili; Li, Li; More

Inflammatory Bowel Diseases. 23(10):1817-1824, October 2017.

Author:
Feng, Ting MD

Serum Interleukin 9 Levels Predict Disease Severity and the Clinical Efficacy of Infliximab in Patients with Crohn's Disease

Feng, Ting; Chen, Baili; Li, Li; More

Inflammatory Bowel Diseases. 23(10):1817-1824, October 2017.

Genetic and Transcriptomic Bases of Intestinal Epithelial Barrier Dysfunction in Inflammatory Bowel Disease

Vancamelbeke, Maaike; Vanuytsel, Tim; Farré, Ricard; More

Inflammatory Bowel Diseases. 23(10):1718-1729, October 2017.

The Current Landscape and Lessons from Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Past, Present, and Future

Allegretti, Jessica; Eysenbach, Lindsay M.; El-Nachef, Najwa; More

Inflammatory Bowel Diseases. 23(10):1710-1717, October 2017.

Guanylate Cyclase C Activation Shapes the Intestinal Microbiota in Patients with Familial Diarrhea and Increased Susceptibility for Crohn's Disease

Tronstad, Rune R.; Kummen, Martin; Holm, Kristian; More

Inflammatory Bowel Diseases. 23(10):1752-1761, October 2017.

Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort

Bramuzzo, Matteo; Stocco, Gabriele; Montico, Marcella; More

Inflammatory Bowel Diseases. 23(10):1810-1816, October 2017.

Frequency and Variables Associated with Fasting Orders in Inpatients with Ulcerative Colitis: The Audit of Diet Orders—Ulcerative Colitis (ADORE-UC) Study

Gallinger, Zane R.; Rumman, Amir; Pivovarov, Kevin; More

Inflammatory Bowel Diseases. 23(10):1790-1795, October 2017.

Prevalence and Phenotype of Concurrent Psoriasis and Inflammatory Bowel Disease

Eppinga, Hester; Poortinga, Sietske; Thio, Hok Bing; More

Inflammatory Bowel Diseases. 23(10):1783-1789, October 2017.

Frequency and Variables Associated with Fasting Orders in Inpatients with Ulcerative Colitis: The Audit of Diet Orders—Ulcerative Colitis (ADORE-UC) Study

Gallinger, Zane R.; Rumman, Amir; Pivovarov, Kevin; More

Inflammatory Bowel Diseases. 23(10):1790-1795, October 2017.

Incidence and Management of Recurrence in Patients with Crohn's Disease Who Have Undergone Intestinal Resection: The Practicrohn Study

Domènech, Eugeni; Garcia, Valle; Iborra, Marisa; More

Inflammatory Bowel Diseases. 23(10):1840-1846, October 2017.

Incidence and Management of Recurrence in Patients with Crohn's Disease Who Have Undergone Intestinal Resection: The Practicrohn Study

Domènech, Eugeni; Garcia, Valle; Iborra, Marisa; More

Inflammatory Bowel Diseases. 23(10):1840-1846, October 2017.

Incidence and Management of Recurrence in Patients with Crohn's Disease Who Have Undergone Intestinal Resection: The Practicrohn Study

Domènech, Eugeni; Garcia, Valle; Iborra, Marisa; More

Inflammatory Bowel Diseases. 23(10):1840-1846, October 2017.

Patients with Crohn's Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to Infliximab

Guerbau, Loic; Gerard, Romain; Duveau, Nicolas; More

Inflammatory Bowel Diseases. 23(10):1853-1859, October 2017.

Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort

Bramuzzo, Matteo; Stocco, Gabriele; Montico, Marcella; More

Inflammatory Bowel Diseases. 23(10):1810-1816, October 2017.

Guanylate Cyclase C Activation Shapes the Intestinal Microbiota in Patients with Familial Diarrhea and Increased Susceptibility for Crohn's Disease

Tronstad, Rune R.; Kummen, Martin; Holm, Kristian; More

Inflammatory Bowel Diseases. 23(10):1752-1761, October 2017.

Delivering High Value Inflammatory Bowel Disease Care Through Telemedicine Visits

Li, Shawn X.; Thompson, Kimberly D.; Peterson, Tracey; More

Inflammatory Bowel Diseases. 23(10):1678-1681, October 2017.

High Demand for Psychotherapy in Patients with Inflammatory Bowel Disease

Klag, Thomas; Mazurak, Nazar; Fantasia, Laura; More

Inflammatory Bowel Diseases. 23(10):1796-1802, October 2017.

Premedication Use in Preventing Acute Infliximab Infusion Reactions in Patients with Inflammatory Bowel Disease: A Single Center Cohort Study

Gold, Stephanie L.; Cohen-Mekelburg, Shirley; Schneider, Yecheskel; More

Inflammatory Bowel Diseases. 23(10):1882-1889, October 2017.

Impact of Diagnostic Delay and Associated Factors on Clinical Outcomes in a U.S. Inflammatory Bowel Disease Cohort

Nguyen, Vu Q.; Jiang, Dingfeng; Hoffman, Sharon N.; More

Inflammatory Bowel Diseases. 23(10):1825-1831, October 2017.

  • Video

IBD LIVE Series—Case 8: Treatment Options for Refractory Esophageal Crohn's Disease and Hidradenitis Suppurativa

Iskandar, Heba; Greer, Julia B.; Krasinskas, Alyssa M.; More

Inflammatory Bowel Diseases. 23(10):1667-1677, October 2017.

  • Video